Clinical Trial Update: Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease

View source ↗

Summary

AstraZeneca-sponsored clinical trial completed evaluating daily COPD symptom variability and the impact of symptoms on morning activities. The study involved pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED